Cargando…
Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta
INTRODUCTION: Bisphosphonates are currently the medical treatment most often used in children with osteogenesis imperfecta (OI). The purpose of this retrospective pre–post study was to evaluate the efficacy of treatment with bisphosphonates. We measured the effect by evaluating the number of outpati...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058211/ https://www.ncbi.nlm.nih.gov/pubmed/21594080 http://dx.doi.org/10.1007/s11832-010-0305-3 |
_version_ | 1782200354836840448 |
---|---|
author | de Graaff, F. Verra, W. Pruijs, J. E. H. Sakkers, R. J. B. |
author_facet | de Graaff, F. Verra, W. Pruijs, J. E. H. Sakkers, R. J. B. |
author_sort | de Graaff, F. |
collection | PubMed |
description | INTRODUCTION: Bisphosphonates are currently the medical treatment most often used in children with osteogenesis imperfecta (OI). The purpose of this retrospective pre–post study was to evaluate the efficacy of treatment with bisphosphonates. We measured the effect by evaluating the number of outpatient department consultations and operative interventions before and after treatment with bisphosphonates in children with OI. METHODS AND MATERIALS: Outpatient department consultation and operative intervention frequencies before and after treatment with bisphosphonates were registered. Children who had at least 2 years of medical records before treatment and at least 2 years after treatment were used in this study. RESULTS: Of 118 children who were treated with bisphosphonates, 51 (23 boys and 28 girls) fulfilled the inclusion criteria. Statistical analysis revealed a significant decrease in outpatient department consultations (P < 0.000) and operative intervention (P < 0.003) before and after bisphosphonate treatment. CONCLUSION: The pre-post design of our study shows a significant reduction of the number of outpatient department consultations and operative interventions in patients with OI after treatment with bisphosphonates. |
format | Text |
id | pubmed-3058211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-30582112011-04-05 Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta de Graaff, F. Verra, W. Pruijs, J. E. H. Sakkers, R. J. B. J Child Orthop Original Clinical Article INTRODUCTION: Bisphosphonates are currently the medical treatment most often used in children with osteogenesis imperfecta (OI). The purpose of this retrospective pre–post study was to evaluate the efficacy of treatment with bisphosphonates. We measured the effect by evaluating the number of outpatient department consultations and operative interventions before and after treatment with bisphosphonates in children with OI. METHODS AND MATERIALS: Outpatient department consultation and operative intervention frequencies before and after treatment with bisphosphonates were registered. Children who had at least 2 years of medical records before treatment and at least 2 years after treatment were used in this study. RESULTS: Of 118 children who were treated with bisphosphonates, 51 (23 boys and 28 girls) fulfilled the inclusion criteria. Statistical analysis revealed a significant decrease in outpatient department consultations (P < 0.000) and operative intervention (P < 0.003) before and after bisphosphonate treatment. CONCLUSION: The pre-post design of our study shows a significant reduction of the number of outpatient department consultations and operative interventions in patients with OI after treatment with bisphosphonates. Springer Berlin Heidelberg 2011-01-25 2011-04 /pmc/articles/PMC3058211/ /pubmed/21594080 http://dx.doi.org/10.1007/s11832-010-0305-3 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is published under license to BioMed Central Ltd. Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Original Clinical Article de Graaff, F. Verra, W. Pruijs, J. E. H. Sakkers, R. J. B. Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta |
title | Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta |
title_full | Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta |
title_fullStr | Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta |
title_full_unstemmed | Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta |
title_short | Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta |
title_sort | decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta |
topic | Original Clinical Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058211/ https://www.ncbi.nlm.nih.gov/pubmed/21594080 http://dx.doi.org/10.1007/s11832-010-0305-3 |
work_keys_str_mv | AT degraafff decreaseinoutpatientdepartmentvisitsandoperativeinterventionsduetobisphosphonatesinchildrenwithosteogenesisimperfecta AT verraw decreaseinoutpatientdepartmentvisitsandoperativeinterventionsduetobisphosphonatesinchildrenwithosteogenesisimperfecta AT pruijsjeh decreaseinoutpatientdepartmentvisitsandoperativeinterventionsduetobisphosphonatesinchildrenwithosteogenesisimperfecta AT sakkersrjb decreaseinoutpatientdepartmentvisitsandoperativeinterventionsduetobisphosphonatesinchildrenwithosteogenesisimperfecta |